Covington Capital Management Eli Lilly & CO Transaction History

Covington Capital Management

$23.2 Billion
Q3 2022

A detailed history of Covington Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Covington Capital Management holds 14,630 shares of LLY stock, worth $11.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

14,630

Previous 14,490 0.97%

Holding current value

$11.8 Million

Previous $4.7 Million 0.7%

% of portfolio

0.02%

Previous 0.19%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $41,507 - $47,301	140 Added 0.97%	14,630 $4.73 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $538,227 - $631,958	1,931 Added 15.38%	14,490 $4.7 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $1.1 Million - $1.37 Million	4,702 Added 59.84%	12,559 $3.6 Million
Q4 2021 Feb 16, 2022	BUY	$224.85 - $279.04 $4,047 - $5,022	18 Added 0.23%	7,857 $2.17 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $8,864 - $10,908	40 Added 0.51%	7,839 $1.81 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $138,481 - $179,125	767 Added 10.91%	7,799 $1.79 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $23,333 - $30,206	-142 Reduced 1.98%	7,032 $1.31 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $11,610 - $15,364	89 Added 1.26%	7,174 $1.21 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $7,311 - $8,456	50 Added 0.71%	7,085 $1.05 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $4,365 - $5,253	-32 Reduced 0.45%	7,035 $1.16 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $16,667 - $20,629	140 Added 2.02%	7,067 $980,000
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $15,289 - $18,937	143 Added 2.11%	6,927 $910,000
Q3 2019 Nov 18, 2019	SELL	$106.79 - $116.16 $279,362 - $303,874	-2,616 Reduced 27.83%	6,784 $759,000
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $63,540 - $71,184	600 Added 6.82%	9,400 $1.09 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $598,873 - $748,487	-6,975 Reduced 44.22%	8,800 $944,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $1,892 - $2,172	25 Added 0.16%	15,775 $1.35 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $298,695 - $352,590	-4,025 Reduced 20.35%	15,750 $1.22 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $4,097 - $4,394	-50 Reduced 0.25%	19,775 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $356,448 - $395,622	4,625 Added 30.43%	19,825 $1.7 Million
Q2 2017 Aug 16, 2017	BUY	N/A	15,200	15,200 $1.25 Million

Others Institutions Holding LLY

# of Institutions

4,045

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $765B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.

Account

Covington Capital Management Eli Lilly & CO Transaction History